智通财经APP讯,三生国健(688336.SH)公告,公司SSGJ-627注射液收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,同意公司开展SSGJ-627注射液溃疡性结肠炎(UC)的I期临床试验。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.